• SENSEX
    NIFTY 50
Market

Glenmark Pharma shares rally 40% to fresh 52-week high on launch of antiviral drug Favipiravir

Updated : June 22, 2020 12:23 PM IST

Glenmark is now embarking on a second trial for a combination of two anti-viral drugs Favipiravir (An approved drug for novel flu pandemics) with Umifenovir (An approved drug for Influenza)
Glenmark Pharma shares rally 40% to fresh 52-week high on launch of antiviral drug Favipiravir

You May Also Like

Live TV
Advertisement